References
- D., Gansevoort, R. T., Dullaart, P. F. & De, Jong, P. E. Angiotensin II antagonism improves the lipoprotein profile in patients with nephrotic syndrome. Journal of Hypertension suppl 13:53–58,1995.
- Gansevoort, R. T., de, Zeeuw, D., Shahinfar, S., Redfield, A. & de, Jong, P. E.: Effects of the angiotensin II antago-nist losartan in hypertensive patients with renal disease. J Hypertens Suppl 12:37–42,1994.
- Gansevoort, R. T., Heeg, J. E., Vriesendorp, R., de, Zeeuw, D. & de, Jong, P. E.: Antiproteinuric drugs in patients with idiopathic membranous glomerulopathy. Nephrol Dial Transplant Suppl 1:91–96,1992.
- Gertz, M. A. & Kyle, R. A.: Secondary systemic amyloidosis: response and survival in 64 patients. Medicine 70:246-256,1991.
- Hebert, L. A., Falkenhain, M. E., Nahman, N. S., Cosio, F. G. & O'Dorisio, T. M.: Combination ACE inhibitor and angiotensin II receptor antagonist therapy in diabetic nephropathy. Am J Nephrol 19:1-6,1999.
- Ichikawa, I.: Will angiotensin II receptor antagonist be renoprotective in humans? Kidney Int 50:684-692,1996. Kaysen, G. A., Gambertoglio, J., Jiminez, I., Jones, H. & Hutchinson, F. N.: Effect of dietary protein intake on albu-min homeostasis in nephrotic patients. Kidney Int 29:572–577,1986.
- Lewis, E. J., Hunsicker, L. G., Bain, R. P. & Rahde, R. D.: The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456–1462,1993.
- Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins., R. C., Rohde, R. & Raz, I.: Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851-860,2001.
- Orth, S. R. & Ritz, E.: The Nephrotic Syndrome. N Eng J Med 338:1202–1211,1998.
- Peters, H., Border, W. A. & Noble, N. A.: Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis. Kidney Int 57:1493–1501,2000.
- Praga, M., Hernández, E., Montoyo, C., Andres, A., Ruilope, L. M. & Rodicio, J. L.: Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 20:240-248, 1992.
- Russo, D., Pisani, A., Balletta, M. M., De, Nicola, L., Savino, F. A., Andreucci, M. & Minutolo, R.: Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy. Am J Kidney Dis 33:851-856,1999.
- Thomas, D.M., Hillis, AN., Coles, G.A., Davies, M. & Williams, J.D.: Enalapril can treat the proteinuria of mem-branous glomerulonephritis without detriment to systemic or renal hemodynamics. Am J Kidney Dis 18:38-43, 1991.
- Weidmann, P., Boehlen, L. M. & Courten, M.: Effects of different antihypertensive drugs on human diabetic pro-teinuria. Nephrol Dial Transplant 8:582–584,1993.
- Zoccali, C., Valvo, E., Russo, D., Panichi, V. & Zuccala, A.: Antiproteinuric effect of Losartan in patients with chronic renal diseases. Nephrol Dial Transplant 12:234–235,1997.